Article
Allogeneic bone marrow transplantation for relapsed and refractory lymphoma using genotypically HLA-identical and alternative donors.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology - 1 Oct 1991
Lundberg J H, Hansen R M, Chitambar C R, Lawton C A, Gottlieb M, Anderson T, Ash R C
Abstract excerpt
Twenty-two patients, ages 16.6 to 43.9 years (median age, 30 years), with relapsed or refractory lymphoma were treated by allogeneic bone marrow transplantation after high-dose chemotherapy with or without total body irradiation (TBI). Seven patients had Hodgkin's disease, four had low-grade histology non-Hodgkin's lymphoma (NHL), seven had intermediate-grade NHL, and four had high-grade NHL. Of the 22 patients,...
Topics
- Actuarial Analysis
- Adolescent
- Adult
- Bone Marrow Transplantation
- Female
- Genotype
- Graft vs Host Disease
- HLA Antigens
- Humans
- Lymphoma
- Male
